Celgene reports preliminary earnings

Celgene Corp. (NASDAQ:CELG) said it expects 4Q09 diluted non-GAAP EPS of $0.62, matching the Street's estimate and up 45% from 4Q08. Fourth quarter non-GAAP revenues are expected to come in at about $755 million, above the Street's estimate of $733.1 million and up 20% from 4Q08. The company also said it expects full year diluted non-GAAP EPS of $2.08 and non-GAAP revenue of $2.7 billion, increases of 30% and 20%, respectively, over 2008. Full earnings will be presented on Jan. 28. ...